Literature DB >> 16670640

5-lipoxygenase modulates the alteration of paracellular barrier function in mice ileum during experimental colitis.

Emanuela Mazzon1, Lidia Sautebin, Achille P Caputi, Salvatore Cuzzocrea.   

Abstract

Small intestine permeability is frequently altered in inflammatory bowel disease and may be caused by the translocation of intestinal toxins through leaky small intestine tight junctions (TJs) and adherence. Recently, it has been shown that 5-lipoxygenase (5-LO) plays an important role in the development of various inflammatory conditions like inflammatory bowel disease. In the present study, by comparing the responses in wild-type mice (5-LOWT) with those of mice lacking the 5-lipoxygenase (5-LOKO), we investigated the role played by this enzyme in the permeability and structure of small intestine TJs in an animal model of experimental colitis. To address this question, we used an experimental model of colitis, induced by dinitrobenzene sulfonic acid (DNBS). Four days after colitis induction by DNBS, the ileal TJs were studied by means of transmission electron microscopy using lanthanum nitrate and immunohistochemistry of occludin and ZO-1. When compared with DNBS-treated 5-LOWT mice, DNBS-treated 5-LOKO mice experienced a reduced rate of the extent and severity of the histological signs of colon injury. After administration of DNBS, 5-LOWT mice showed a significant increase of ileal permeability (88.3% +/- 1.2%) compared with sham (5.6% +/- 0.5%). In colitis, the percentage of "leaky" junctions in terminal ilea correlated positively with the macroscopic colon damage score. Distal colitis in 5-LOWT mice induces an increase of TJ permeability throughout the entire small intestine, and the extent of alterations correlates with colonic damage. On the contrary, a significant reduction of (1) the degree of colon injury, (2) the alteration of ZO-1 and occludin localization (immunohistochemistry), and (3) ileal permeability (8.1% +/- 0.7%) caused by DNBS in the colon was observed in 5-LOKO mice. Similarly, the treatment of 5-LOWT with zileuton (50 mg/kg per oral gavage twice a day), a 5-LO inhibitor, resulted in a significant reduction of all the previously described parameters. Taken together, our results clearly demonstrate that 5-LO modulates small intestinal permeability in experimental colitis through the regulation of TJ protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670640     DOI: 10.1097/01.shk.0000209530.30564.22

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  5 in total

1.  Clostridium difficile-induced colitis in mice is independent of leukotrienes.

Authors:  Bruno C Trindade; Casey M Theriot; Jhansi L Leslie; Paul E Carlson; Ingrid L Bergin; Marc Peters-Golden; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2014-09-16       Impact factor: 3.331

2.  PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice.

Authors:  Emanuela Esposito; Emanuela Mazzon; Irene Paterniti; Roberto Dal Toso; Giovanna Pressi; Rocco Caminiti; Salvatore Cuzzocrea
Journal:  PPAR Res       Date:  2010-06-30       Impact factor: 4.964

3.  Effects of zileuton and montelukast in mouse experimental spinal cord injury.

Authors:  T Genovese; A Rossi; E Mazzon; R Di Paola; C Muià; R Caminiti; P Bramanti; L Sautebin; S Cuzzocrea
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

4.  Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury.

Authors:  Marco Failla; Tiziana Genovese; Emanuela Mazzon; Elisa Gili; Carmelo Muià; Mariangela Sortino; Nunzio Crimi; Achille P Caputi; Salvatore Cuzzocrea; Carlo Vancheri
Journal:  Respir Res       Date:  2006-11-21

Review 5.  Emerging Pathological Engagement of Ferroptosis in Gut Diseases.

Authors:  Weihua Gao; Ting Zhang; Hao Wu
Journal:  Oxid Med Cell Longev       Date:  2021-10-25       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.